TIME, a Phase 2b/3 Study Evaluating TG4010 in Combination With First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 2b Results

Élisabeth Quoix, György Losonczy, Frédéric Forget et al. · International Journal of Radiation Oncology*Biology*Physics · 2014

Cited by 3 works. doi:10.1016/j.ijrobp.2014.08.211 Open-access PDF

Authors